시장보고서
상품코드
1482332

색소침착증 치료 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 치료 유형별, 증상별, 최종사용자별, 지역별

Hyperpigmentation Disorder Treatment Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type, Condition, End User, and Geography

발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 158 Pages | 배송안내 : 즉시배송

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

색소침착증 치료 시장 규모는 2022년 66억 8,000만 달러에서 2030년 117억 8,000만 달러로 2022-2030년 연평균 7.4% 성장할 것으로 예측됩니다.

색소침착증 치료 시장의 시장 촉진요인

간반증 유병률 증가

가장 흔한 색소 침착 증상 중 하나인 기미는 얼굴, 특히 턱, 윗입술, 코, 이마, 뺨에 경계가 있는 대칭적인 옅은 색에서 짙은 색의 진흙빛 갈색 반점이 특징입니다. 여성과 피부색이 검은 사람에게 흔합니다. 기미는 입술, 하악 및 얼굴 중앙부의 임상적 특징이 일반적입니다. 2023년 9월 Elsevier BV에 게재된 연구에 따르면, 일반 인구에서 간반의 전체 유병률은 1%-50%로 추정되며, 간반의 55-64%는 여성에서 발생하며, 남성의 경우, 간반의 55-64%는 여성에서 발생합니다. 기미 환자의 55-64%가 같은 증상의 가족력이 있다고 보고했습니다. 또한, 동아시아계, 히스패닉계, 피츠패트릭 피부색(IV-VI)이 높은 환자에서 더 높은 유병률이 보고되고 있습니다.

임신도 기미의 흔한 원인입니다. 이 증상은 경구 피임약이나 호르몬제를 복용하는 여성에게도 영향을 미칩니다. 에스트로겐, 프로게스테론, 멜라닌 세포 자극 호르몬의 농도가 보통 임신 중기에 상승하기 때문에 그 영향도 있을 수 있습니다. 2023년 8월 미국 국립생물공학정보센터(NCBI)에 따르면, 기미는 생식기에 많이 발생하며, 사춘기 이전에는 드물게 발생합니다. 이 증상은 임산부의 15-50%에서 나타나며, 지역에 따라 1.5%-33%의 유병률을 보입니다. 따라서 기미의 유병률 증가는 색소 침착 치료에 대한 수요를 유발합니다.

색소침착증 치료 시장의 기회

색소침착증 치료 시장의 주요 기업들은 혁신적이고 효율적인 제품을 개발 및 출시하기 위해 R&D 활동에 집중하고 있습니다. 또한, 규제 당국의 승인을 받기 위한 노력도 병행하고 있습니다. 다음은 시장 진입 기업에게 충분한 성장 기회를 제공할 것으로 예상되는 최근 제품 개발 및 출시 사례 중 일부입니다.

지난 10월, 갈더마는 스킨케어 업계에서 획기적인 제품인 Skincare A-LUMINATE BRIGHTENING SERUM을 출시했습니다. 알란틴 스킨케어 제품군에 추가된 이 혁신적인 제품은 자극적인 성분을 사용하지 않고도 피부 표면의 색소 침착을 눈에 띄게 완화할 수 있도록 특별히 고안된 제품입니다.

2022년 2월, 알케미(Alchemee)는 노화로 인한 기미, 햇볕에 의한 기미, 피부 색소 침착, 염증 후 색소 침착(PIH) 등 다양한 유형의 피부 변색 및 색소 침착 증상을 개선하는 데 도움이 되는 새로운 브랜드 'Restorative Elements'를 발표했습니다. Restorative Elements는 피부과 전문의가 개발하고 임상적으로 입증된 루틴으로 색소 침착의 눈에 보이는 징후를 안전하고 부드럽게 옅어지도록 처방됐습니다.

2023년 3월, Candela는 미국 식품의약국(FDA)으로부터 카페오레, 색소침착, 기미, 오타모반을 치료하는 PicoWay 레이저에 대한 승인을 받았습니다.

지난 5월, 사이언티스는 색소 침착을 개선하기 위해 처방된 세 가지 제품 시스템인 시스페라 인텐시브 시스템을 출시했습니다.

색소침착증 치료 시장 : 부문별 개요

치료 유형별로 시장은 미용, 광/레이저 치료, 미세박피술, 화학적 박피술, 냉동 요법, 기타로 분류되며, 2022년 색소침착증 치료 시장 점유율은 미용 부문이 가장 큰 비중을 차지할 것으로 예상됩니다. 또한, 미세박피술 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

시장은 증상별로 기미, 일광 흑자, 염증 후 색소 침착, 기타로 분류됩니다. 기미 부문은 2022년 가장 큰 색소침착증 치료 시장 점유율을 차지했습니다. 또한 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

최종사용자별 시장은 병원, 피부과 센터, 기타로 분류됩니다. 병원 부문은 2022년 가장 큰 시장 점유율을 차지할 것으로 예상되며, 피부과 센터 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

색소침착증 치료 시장 지역별 개요

2022년에는 북미가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 색소침착증 치료 서비스를 제공하는 클리닉과 병원의 수가 증가하고 있으며, 미국의 인구 통계학적 변화로 인해 피부색이 짙은 히스패닉 인구가 증가하면서 시장 성장을 촉진하고 있습니다. 그 외 제품 출시 및 승인 수 증가, 미용 클리닉의 급증, 다양한 색소침착 치료 접근성 증가 등이 캐나다 색소침착증 치료 시장의 성장을 촉진하고 있습니다. 예를 들어, 2023년 6월 선 파마 캐나다(Sun Pharma Canada Inc.)는 캐나다 보건부로부터 PRABSORICA LD(이소트레티노인 캡슐)의 승인을 받았습니다. 앱솔리카 LD는 12세 이상의 중증 여드름 환자를 치료하기 위해 10년 만에 개발된 새로운 유일한 이소트레티노인 미분말화 제제입니다.

목차

제1장 소개

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 색소침착증 치료 시장 상황

  • 소개
  • PEST 분석

제5장 색소침착증 치료 시장 - 주요 시장 역학

  • 색소침착증 치료 시장 : 주요 시장 역학
  • 시장 성장 촉진요인
    • 기미 유병률 상승
    • 색소침착 증 인식 제고 프로그램 증가
  • 시장 성장 억제요인
    • 치료비 급등
  • 시장 기회
    • 시장 진출 기업 전략적 대처
  • 향후 동향
    • 절제 레이저 사용
    • PATH-3기술별 신제품
  • 성장 촉진요인과 억제요인의 영향

제6장 색소침착증 치료 시장 - 세계 시장 분석

제7장 색소침착증 치료 시장 분석 - 치료 유형별

  • 코스메슈티컬
  • 빛 또는 레이저 요법
  • 미세박피
  • 케미컬 필링
  • 동결요법
  • 기타

제8장 색소침착증 치료 시장 분석 - 증상별

  • 기미
  • 일광 흑자
  • 염증 후 색소침착
  • 기타

제9장 색소침착증 치료 시장 분석 - 최종사용자별

  • 병원
  • 피부과 센터
  • 기타

제10장 색소침착증 치료 시장 분석 - 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 사우디아라비아
    • 남아프리카공화국
    • 아랍에미리트
    • 기타 중동 및 아프리카
  • 중남미
    • 브라질
    • 아르헨티나
    • 기타 중남미

제11장 색소침착증 치료 시장 : 업계 상황

  • 소개
  • 색소침착증 치료 시장 성장 전략
  • 유기적 성장 전략
  • 무기적 성장 전략
    • 성장 전략

제12장 기업 개요

  • AbbVie Inc
  • EpiPharm AG
  • Galderma SA
  • Obagi Cosmeceuticals LLC
  • Bayer AG
  • Lutronic Co Ltd
  • La Pristine
  • L'OREAL S.A.
  • Pierre Fabre SA
  • Vivier Pharma Inc

제13장 부록

ksm 24.05.28

The hyperpigmentation disorder treatment market size is expected to grow from US$ 6.68 billion in 2022 to US$ 11.78 billion by 2030; it is anticipated to record a CAGR of 7.4% from 2022 to 2030.

Market Drivers of the Hyperpigmentation Disorder Treatment Market

Rise in Prevalence of Melasma

Melasma, one of the most dominant hyperpigmentation conditions, is characterized by symmetrical light to dark muddy-brown macules with borders on the face, particularly the chin, upper lip, nose, forehead, and cheeks. It is prevalent among women and those with darker complexion. Malar, mandibular, and centrofacial clinical features are common in melasma. Sun exposure, hormonal variations, pregnancy, hereditary factors, cosmetics, and medicines have all been linked to the development of melasma. According to a study published in Elsevier BV in September 2023, Various studies have estimated that the overall prevalence of melasma in the general population ranges from 1% to 50%.%. 55-64% of melasma cases have reported a family history of the same condition. Moreover, a greater prevalence is reported in individuals of East Asian and Hispanic origins as well as in patients with high Fitzpatrick skin phototypes (IV to VI); it is also higher in individuals living in locations that receive intense UV radiation.

Pregnancy is another common cause of melasma. This condition also impacts women taking oral contraceptives and hormones. Estrogen, progesterone, and melanocyte-stimulating hormone levels normally rise during the third trimester of pregnancy, which may be a factor. According to the National Center for Biotechnology Information (NCBI) in August 2023, melasma is more common in reproductive years, and it rarely occurs before puberty; the condition occurs in 15-50% of pregnant women, and its prevalence ranges from 1.5% to 33%, depending on the population in a different region. Therefore, an upsurge in melasma prevalence triggers the demand for hyperpigmentation treatments.

Opportunities in the Hyperpigmentation disorder treatment Market

Major hyperpigmentation disorder treatment market players focus on research and development activities to develop and launch innovative and efficient products. They are also making efforts to win regulatory approvals for their products. Some of the recent product developments and launches, which are likely to create ample growth opportunities for market players, are mentioned below.

In October 2022, Galderma introduced Skincare A-LUMINATE BRIGHTENING SERUM, a breakthrough product in the skincare industry. This innovative addition to the ALASTIN Skincare range is specifically formulated to lower the appearance of surface hyperpigmentation without the use of harsh or irritating ingredients.

In February 2022, Alchemee introduced the new Restorative Elements brand to help in the correction of the appearance of various types of skin discoloration and hyperpigmentation symptoms, including age spots, sun spots, uneven skin tone, and post-inflammatory hyperpigmentation (PIH). The Restorative Elements is a dermatologist-developed, clinically-proven routine formulated to safely and gently help fade the visible signs of skin hyperpigmentation.

In March 2023, Candela Corporation won the US Food and Drug Administration (FDA) approval for its PicoWay laser designed to treat cafe au lait, lenHtigines, melasma, and Nevus of Ota.

In May 2022, Scientis launched the Cyspera Intensive System, a three-product system formulated to improve hyperpigmentation.

Hyperpigmentation disorder treatment Market: Segmental Overview

By treatment type, the market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest hyperpigmentation disorder treatment market share in 2022. Further, the microdermabrasion segment is anticipated to register the highest CAGR during the forecast period.

The market, by condition, is categorized into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest hyperpigmentation disorder treatment market share in 2022. It is further anticipated to register the highest CAGR during the forecast period.

The market, by end user, is categorized into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022, Further, the dermatology centers segment is anticipated to register the highest CAGR during the forecast period.

Hyperpigmentation disorder treatment Market: Geographical Overview

In 2022, North America held the largest share of the market. The increasing numbers of clinics and hospitals providing hyperpigmentation disorder treatment services, and an evolving demographics of the US with the growth of Hispanic population with a dark skin type is driving the growth of the market. Other factors such as the increasing number of product launches and approvals, the surging number of aesthetic clinics, and growing access to numerous hyperpigmentation treatments propel the hyperpigmentation disorder treatment market growth in Canada. For instance, in June 2023, Sun Pharma Canada Inc. received Health Canada's approval of PRABSORICA LD (isotretinoin capsules). ABSORICA LD is a new and only micronized formulation of isotretinoin, which is the first formulation developed in over a decade to treat severe acne in patients aged 12 and older.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Hyperpigmentation Disorder Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Hyperpigmentation Disorder Treatment Market - Key Market Dynamics

  • 5.1 Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rise in Prevalence of Melasma
    • 5.2.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Treatments
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Use of Ablative Lasers
    • 5.5.2 Novel Products Based on PATH-3 Technology
  • 5.6 Impact of Drivers and Restraints:

6. Hyperpigmentation Disorder Treatment Market - Global Market Analysis

7. Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type

  • 7.1 Cosmeceutical
    • 7.1.1 Overview
    • 7.1.2 Cosmeceutical: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Light or Laser Therapy
    • 7.2.1 Overview
    • 7.2.2 Light or Laser Therapy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Microdermabrasion
    • 7.3.1 Overview
    • 7.3.2 Microdermabrasion: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Chemical Peels
    • 7.4.1 Overview
    • 7.4.2 Chemical Peels: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Cryotherapy
    • 7.5.1 Overview
    • 7.5.2 Cryotherapy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Hyperpigmentation Disorder Treatment Market Analysis - by Condition

  • 8.1 Melasma
    • 8.1.1 Overview
    • 8.1.2 Melasma: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Solar Lentigines
    • 8.2.1 Overview
    • 8.2.2 Solar Lentigines: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Post-inflammatory Hyperpigmentation
    • 8.3.1 Overview
    • 8.3.2 Post-inflammatory Hyperpigmentation: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Hyperpigmentation Disorder Treatment Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Dermatology Centers
    • 9.2.1 Overview
    • 9.2.2 Dermatology Centers: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Hyperpigmentation Disorder Treatment Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Hyperpigmentation Disorder Treatment Market Overview
    • 10.2.2 North America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.2.2.1 North America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Treatment Type
      • 10.2.2.2 North America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Condition
      • 10.2.2.3 North America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by End User
    • 10.2.3 North America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.1 North America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.2 US
      • 10.2.3.3 US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.3.1 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.2.3.3.2 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.2.3.3.3 US: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.2.3.4 Canada
      • 10.2.3.5 Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.5.1 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.2.3.5.2 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.2.3.5.3 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.2.3.6 Mexico
      • 10.2.3.7 Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.7.1 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.2.3.7.2 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.2.3.7.3 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Hyperpigmentation Disorder Treatment Market Overview
    • 10.3.2 Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.3.2.1 Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Treatment Type
      • 10.3.2.2 Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Condition
      • 10.3.2.3 Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by End User
    • 10.3.3 Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.1 Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.2 Germany
      • 10.3.3.3 Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.3.1 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.3.3.3.2 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.3.3.3.3 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.3.3.4 UK
      • 10.3.3.5 UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.5.1 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.3.3.5.2 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.3.3.5.3 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.3.3.6 France
      • 10.3.3.7 France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.7.1 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.3.3.7.2 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.3.3.7.3 France: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.3.3.8 Italy
      • 10.3.3.9 Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.9.1 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.3.3.9.2 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.3.3.9.3 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.3.3.10 Spain
      • 10.3.3.11 Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.11.1 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.3.3.11.2 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.3.3.11.3 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.3.3.12 Rest of Europe
      • 10.3.3.13 Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.13.1 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.3.3.13.2 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.3.3.13.3 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Hyperpigmentation Disorder Treatment Market Overview
    • 10.4.2 Asia Pacific: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.4.2.1 Asia Pacific: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Treatment Type
      • 10.4.2.2 Asia Pacific: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Condition
      • 10.4.2.3 Asia Pacific: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by End User
    • 10.4.3 Asia Pacific: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.1 Asia Pacific: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.2 China
      • 10.4.3.3 China: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.3.1 China: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.4.3.3.2 China: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.4.3.3.3 China: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.4.3.4 Japan
      • 10.4.3.5 Japan: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.5.1 Japan: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.4.3.5.2 Japan: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.4.3.5.3 Japan: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.4.3.6 India
      • 10.4.3.7 India: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.7.1 India: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.4.3.7.2 India: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.4.3.7.3 India: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.4.3.8 Australia
      • 10.4.3.9 Australia: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.9.1 Australia: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.4.3.9.2 Australia: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.4.3.9.3 Australia: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.4.3.10 South Korea
      • 10.4.3.11 South Korea: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.11.1 South Korea: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.4.3.11.2 South Korea: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.4.3.11.3 South Korea: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.4.3.12 Rest of APAC
      • 10.4.3.13 Rest of APAC: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.13.1 Rest of APAC: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.4.3.13.2 Rest of APAC: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.4.3.13.3 Rest of APAC: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Hyperpigmentation Disorder Treatment Market Overview
    • 10.5.2 Middle East and Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.5.2.1 Middle East and Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Treatment Type
      • 10.5.2.2 Middle East and Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Condition
      • 10.5.2.3 Middle East and Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by End User
    • 10.5.3 Middle East and Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.1 Middle East and Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.2 Saudi Arabia
      • 10.5.3.3 Saudi Arabia: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.3.1 Saudi Arabia: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.5.3.3.2 Saudi Arabia: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.5.3.3.3 Saudi Arabia: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.5.3.4 South Africa
      • 10.5.3.5 South Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.5.1 South Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.5.3.5.2 South Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.5.3.5.3 South Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.5.3.6 UAE
      • 10.5.3.7 UAE: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.7.1 UAE: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.5.3.7.2 UAE: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.5.3.7.3 UAE: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.5.3.8 Rest of Middle East and Africa
      • 10.5.3.9 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.9.1 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.5.3.9.2 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.5.3.9.3 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Hyperpigmentation Disorder Treatment Market Overview
    • 10.6.2 South and Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.6.2.1 South and Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Treatment Type
      • 10.6.2.2 South and Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Condition
      • 10.6.2.3 South and Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by End User
    • 10.6.3 South and Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.6.3.1 South and Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 10.6.3.2 Brazil
      • 10.6.3.3 Brazil: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.6.3.3.1 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.6.3.3.2 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.6.3.3.3 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.6.3.4 Argentina
      • 10.6.3.5 Argentina: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.6.3.5.1 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.6.3.5.2 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.6.3.5.3 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 10.6.3.6 Rest of South and Central America
      • 10.6.3.7 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.6.3.7.1 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 10.6.3.7.2 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 10.6.3.7.3 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by End User

11. Hyperpigmentation Disorder Treatment Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 AbbVie Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 EpiPharm AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Galderma SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Obagi Cosmeceuticals LLC
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bayer AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lutronic Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 La Pristine
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 L'OREAL S.A.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Pierre Fabre SA
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Vivier Pharma Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제